₩52,100.00 ($38.78)

-1300.00 (-2.43%)

Weekly Expected Move ±4.5%

₩47431 ₩49766 ₩52100 ₩54434 ₩56769

KOE · Healthcare · Medical - Specialties · Tech Score Sell · Power 32 · ₩695.1B mcap · 8M float · 1.37% daily turnover

Revenue

$233.9B +14.4% ▲

5Y CAGR: +16.9%

Gross Profit

$174.3B +10.1% ▲

5Y CAGR: +18.7%

Operating Income

$36.1B -1.8% ▼

5Y CAGR: +13.6%

Net Income

$30.6B -7.6% ▼

5Y CAGR: +11.8%

EPS (Diluted)

$2272.33 -10.8% ▼

5Y CAGR: +11.2%

EBITDA

$44.7B -12.9% ▼

5Y CAGR: +12.1%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$137.8B	$160.0B	$170.4B	$204.5B	$233.9B
YoY Growth	+28.7%	+16.1%	+6.5%	+20.0%	+14.4%
Cost of Revenue	$40.0B	$42.9B	$38.5B	$46.2B	$59.7B
Gross Profit	$97.9B	$117.1B	$131.8B	$158.2B	$174.3B
Gross Margin	71.0%	73.2%	77.4%	77.4%	74.5%
R&D Expenses	$8.1B	$8.8B	$9.3B	$12.3B	$0
SG&A Expenses	$52.4B	$25.7B	$32.6B	$45.1B	$0
Operating Expenses	$62.0B	$75.0B	$87.4B	$121.5B	$138.2B
Operating Income	$35.9B	$40.7B	$44.5B	$36.7B	$36.1B
Operating Margin	26.0%	25.4%	26.1%	18.0%	15.4%
Interest Expense	$104M	$122M	$330M	$384M	$504M
Income Before Tax	$39.2B	$42.6B	$44.6B	$43.9B	$38.6B
Tax Expense	$5.4B	$8.7B	$8.0B	$11.1B	$8.6B
Net Income	$34.0B	$33.8B	$36.7B	$33.1B	$30.6B
Net Margin	24.7%	21.1%	21.6%	16.2%	13.1%
EPS (Diluted)	$2612.57	$2595.83	$2819.01	$2546.18	$2272.33
EBITDA	$43.8B	$48.0B	$48.8B	$51.3B	$44.7B
Shares Outstanding	13M	13M	13M	13M	13M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$50.7B	$55.1B	$55.6B	$56.2B	$59.8B	$62.4B	$68.4B	$73.3B
Cost of Revenue	$10.3B	$13.1B	$13.3B	$11.0B	$15.1B	$15.4B	$18.8B	$16.0B
Gross Profit	$40.4B	$42.0B	$42.3B	$45.1B	$44.7B	$47.0B	$49.7B	$57.2B
Gross Margin	79.6%	76.3%	76.0%	80.3%	74.7%	75.3%	72.6%	78.1%
R&D Expenses	$3.0B	$3.2B	$2.8B	$2.3B	$2.7B	$3.3B	$2.7B	$0
SG&A Expenses	$11.5B	$12.5B	$30.4B	$13.5B	$12.9B	$14.8B	$15.3B	$16.7B
Operating Expenses	$30.6B	$34.5B	$35.3B	$34.7B	$33.3B	$37.6B	$36.7B	$39.5B
Operating Income	$9.8B	$7.5B	$7.0B	$10.4B	$9.8B	$9.4B	$13.0B	$17.7B
Operating Margin	19.4%	13.6%	12.6%	18.5%	16.3%	15.0%	19.0%	24.2%
Interest Expense	$97M	$98M	$97M	$85M	$146M	$176M	$104M	$88M
Income Before Tax	$9.2B	$11.8B	$8.0B	$9.0B	$11.8B	$9.9B	$17.9B	$21.3B
Tax Expense	$1.8B	$3.4B	$1.2B	$1.6B	$2.4B	$3.5B	$1.6B	$6.8B
Net Income	$7.4B	$8.6B	$7.0B	$7.6B	$9.6B	$6.4B	$16.3B	$14.2B
Net Margin	14.7%	15.6%	12.6%	13.5%	16.1%	10.3%	23.8%	19.3%
EPS (Diluted)	$571.00	$675.11	$552.77	$611.00	$791.00	$480.87	$1224.00	$1061.00
EBITDA	$11.0B	$13.6B	$8.9B	$47.2B	$14.0B	$11.9B	$15.3B	$20.1B
Shares Outstanding	13M	13M	13M	13M	12M	13M	13M	14M

041830.KQ KOE